Oral-ibuprofen-induced acute renal failure in a preterm infant

Area of Science:

• Neonatal pharmacology
• Pediatric cardiology
• Nephrology

Background:

• Indomethacin, a common treatment for patent ductus arteriosus in preterm neonates, presents significant side effects including necrotizing enterocolitis and renal dysfunction.
• The search for safer alternatives has focused on ibuprofen, with intravenous formulations demonstrating efficacy comparable to indomethacin.

Observation:

• Oral ibuprofen is an experimental approach for patent ductus arteriosus closure in preterm infants, offering theoretical benefits but carrying potential risks.
• A case study documented transient, severe acute renal failure in a preterm infant following administration of oral ibuprofen.

Findings:

• The case highlights a potential serious adverse event associated with oral ibuprofen use in a vulnerable preterm population.
• The pharmacokinetics of oral ibuprofen in neonates require further investigation to understand its safety profile.

Implications:

• Clinicians should exercise caution when considering oral ibuprofen for ductal closure in preterm neonates due to the risk of acute renal failure.
• This case underscores the need for comprehensive safety and pharmacokinetic studies before widespread adoption of oral ibuprofen in neonatal critical care.